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ABSTRACT
Smoking and caffeine consumption showa strong positive correlation, but themechanism underlying this association is un-
clear. Explanations include shared genetic/environmental factors or causal effects. This study employed three methods to in-
vestigate the association between smoking and caffeine. First, bivariate genetic models were applied to data of 10368 twins
from the Netherlands Twin Register in order to estimate genetic and environmental correlations between smoking and caf-
feine use. Second, from the summary statistics ofmeta-analyses of genome-wide association studies on smoking and caffeine,
the genetic correlation was calculated by LD-score regression. Third, causal effects were tested using Mendelian randomiza-
tion analysis in 6605 Netherlands Twin Register participants and 5714 women from the Avon Longitudinal Study of Par-
ents and Children. Through twin modelling, a genetic correlation of r0.47 and an environmental correlation of r0.30 were
estimated between current smoking (yes/no) and coffee use (high/low). Between current smoking and total caffeine use, this
was r0.44 and r0.00, respectively. LD-score regression also indicated sizeable genetic correlations between smoking and cof-
fee use (r0.44 between smoking heaviness and cups of coffee per day, r0.28 between smoking initiation and coffee use and
r0.25 between smoking persistence and coffee use). Consistent with the relatively high genetic correlations and lower envi-
ronmental correlations, Mendelian randomization provided no evidence for causal effects of smoking on caffeine or vice
versa. Genetic factors thus explain most of the association between smoking and caffeine consumption. These ﬁndings sug-
gest that quitting smoking may be more difﬁcult for heavy caffeine consumers, given their genetic susceptibility.
Keywords ALSPAC, caffeine, LD-score regression, Mendelian randomization, smoking, twin modelling.
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INTRODUCTION
A recent study in two large European cohorts (one Dutch
and one British) showed a strong positive correlation be-
tween smoking behaviour and caffeine consumption
(Treur et al. 2016). When analyzing coffee, tea, cola
and energy drinks separately, the strongest associations
were found for coffee. Others have also demonstrated that
smoking is associated with an increased consumption of
coffee (Swanson, Lee, & Hopp 1994; Freedman et al.
2012) and of total caffeine (Hewlett & Smith 2006).
Smoking and caffeine consumption are both inﬂu-
enced by genetic factors. In a Dutch twin study, 44% of
individual differences in smoking initiation were ex-
plained by genetic factors, while for nicotine dependence,
this was 75% (Vink, Willemsen, & Boomsma 2005). The
heritability estimates for coffee/caffeine use range from
36% to 77% (see overview in Vink, Staphorsius, &
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Boomsma 2009). Strong associations between smoking
and caffeine use may therefore be the result of shared ge-
netic and/or environmental factors. The bivariate twin
model estimates genetic and environmental inﬂuences
on two traits and on their overlap by comparing the re-
semblance in monozygotic (MZ) twin pairs to the resem-
blance in dizygotic (DZ) twin pairs. Few studies have
applied this model to smoking and caffeine consumption.
In American male twin pairs from the ‘Twin Registry of
White male World War II veterans’, the observational as-
sociation between number of cigarettes smoked per day,
number of alcoholic drinks per week and number of cups
of coffee per day was completely due to genetic factors
(Swan, Carmelli, & Cardon 1996), while both genetic
and non-shared (unique) environmental factors contrib-
uted to the association between heavy smoking and
heavy coffee drinking (Swan, Carmelli, & Cardon 1997).
In men and women from the ‘Virginia Twin Registry’,
number of cigarettes smoked per day, alcoholic drinks
per week and total caffeine consumption were associated
because of genetic and unique environmental factors
(Hettema, Corey, & Kendler 1999). In male twin pairs
from the same registry, the common environment that
is shared by twins explained the correlation between caf-
feine consumption and cigarettes per day in adolescence.
As participants aged, these common environmental inﬂu-
ences gradually decreased to zero, and genetic inﬂuences
increased (Kendler et al. 2008).
Recently, a novel technique to estimate genetic corre-
lation between two traits, LD (linkage disequilibrium)-
score regression (Bulik-Sullivan et al. 2015b), was devel-
oped. This method utilizes the effect size estimates of all
included single nucleotide polymorphisms (SNPs) in
genome-wide association (GWA) meta-analyses, to esti-
mate genetic correlation between two traits. When calcu-
lating correlations among 25 phenotypes (ranging from
schizophrenia to coronary artery disease), results were
similar to genetic correlations estimated with individual
genotype data (Bulik-Sullivan et al. 2015a). To our
knowledge, LD-score regression has not yet been applied
to GWA meta-analyses on smoking (TAG 2010) and caf-
feine use (Cornelis et al. 2014).
The presence of both genetic and environmental cor-
relations is consistent with causal effects underlying the
association between traits (De Moor et al. 2008). Experi-
mental work in animals and humans has provided evi-
dence for causal effects of smoking on caffeine use
(Joeres et al. 1988; Langmann et al. 2000; Benowitz,
Peng, & Jacob 2003) and of caffeine use on smoking
(Shoaib et al. 1999; Gasior et al. 2002; Rezvani et al.
2013). Mendelian randomization (MR) analysis can be
employed to test causality (Davey Smith & Ebrahim
2003; Palmer et al. 2012; Davey Smith & Hemani
2014). MR utilizes one or several genetic variants
robustly associated with a certain trait as an ‘instru-
ment’, or proxy, for that same trait. Because of the ran-
dom nature of genetic assortment, variants that are
associated with a particular trait should not be associated
with confounding factors. Furthermore, outcome mea-
sures cannot affect the genes that an individual is born
with, removing the possibility of reverse causation. Bidi-
rectional MR, where the effect of a genetic variant for
heaviness of smoking (TAG 2010) on caffeine consump-
tion, and the effect of eight genetic variants for caffeine
consumption (Cornelis et al. 2014) on smoking behav-
iour, is tested, could unravel a possible causal association
between smoking and caffeine.
We used these three methods to clarify the nature of
the association between smoking and caffeine use. First,
in a large sample of 10 368 twins from the Netherlands
Twin Register (NTR), bivariate genetic models were ap-
plied to data on smoking and caffeine consumption. Sec-
ond, genetic correlation between smoking and caffeine
was computed with LD-score regression, utilizing data
from recent GWA meta-analyses. Third, in a sample of
6605 participants from the NTR and 5714 from the
Avon Longitudinal Study of Parents and Children
(ALSPAC), causal effects were tested using bidirectional
MR.
MATERIALS AND METHODS
Figure 1 provides an overview of the three methods, with
the corresponding aims, study samples/data, smoking
measures, caffeine measures and statistical analyses.
More detailed information on each of the approaches is
provided as follows.
Study samples/data
The Netherlands Twin Register
The NTR is an ongoing longitudinal study of Dutch
twins and their family members (Willemsen et al. 2013).
The 10th NTR survey sent in 2013–2014 contained
questions on an extensive list of caffeinated and decaffein-
ated drinks (including coffee, tea, cola and energy drinks)
and on smoking behaviour. The ﬁfth NTR survey sent in
2000 contained questions on (caffeinated) coffee con-
sumption and smoking. For those who did not complete
the 10th survey, data from the ﬁfth survey were included.
NTR participants were included in the bivariate twin
modelling analyses (method 1) and in the MR analyses
(method 3).
A total of 10 368 twins with data on smoking and
coffee use were available for bivariate modelling {mean
age=32.5 [standard deviation (SD) 14.5], 68.1% female,
6866 twins from complete pairs and 3502 twins from
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incomplete pairs}. Of this total, 1425 twins were mono-
zygotic male (MZM), 907 dizygotic male (DZM), 3541
monozygotic female (MZF), 1948 dizygotic female (DZF)
and 2547 dizygotic opposite sex (DOS). For 8060 twins,
there were data on smoking and total caffeine use (mean
age=33.7 [SD 15.3], 69.0% female, 4778 twins from
complete pairs and 3282 twins from incomplete pairs).
In this group, there were 1089 MZM, 677 DZM, 2837
MZF, 1498 DZF and 1959 DOS twins.
For MR analysis, phenotype and genotype data were
available in up to 6605 NTR participants (mean
age=42.7 [SD 16.7], 66.4% female), of which 1415
had data on smoking and coffee only.
The Avon Longitudinal Study of Parents and Children
The Avon Longitudinal Study of Parents and Children is a
prospective cohort study that recruited 14541 pregnant
women who resided in the county of Avon in the UK and
who had expected delivery dates ranging between 1 April
1991 and 31 December 1992. The ALSPAC Ethics and
Law Committee and the Local Research Ethics Commit-
tees gave ethical approval for the study. An elaborate ac-
count of ALSPAC and its methods is given elsewhere
(Boyd et al. 2012; Fraser et al. 2013). Questions on
smoking and caffeinated and decaffeinated coffee, tea
and cola consumption were asked in surveys sent to the
mothers during pregnancy at 18weeks gestation,
32weeks gestation and after delivery when the child
was aged 2, 47, 85, 97 and 145months. Analyses were
performed for all timepoints, but only the results from
when the child was 47months are reported. This speciﬁc
timepoint was selected because the sample size was large
and because during and immediately after pregnancy,
smoking behaviour and caffeine use may be different.
Please note that the study website contains details of all
the data that are available through a fully searchable
data dictionary (www.bris.ac.uk/alspac/researchers/
data-access/data-dictionary).
Participants registered at ALSPAC were included in
the MR analyses (method 3). Phenotype and genotype
data of 5714 participants were available (mean
age=33.4 [SD 4.5]).
Genotype data
Single nucleotide polymorphism data were available from
genome-wide SNP arrays. In the NTR sample, these data
were collected through several projects between 2004
and 2008. Adult participants (18+) who had partici-
pated in NTR research at least once were selected for
genotyping. Full details on the data collection and
genotyping methods in NTR can be found elsewhere
(Willemsen et al. 2010; Nivard et al. 2014). In ALSPAC,
DNA was extracted from blood samples that were col-
lected from 10000 mothers during their normal antena-
tal care. More details on the collection of DNA and
genotyping methods in ALSPAC are provided elsewhere
(Jones et al. 2000; Hinds et al. 2013). Genotype data were
utilized in the MR analyses (method 3).
Genetic risk for smoking was reﬂected by SNP
rs1051730, located in the CHRNA3 gene at chromo-
some 15 and robustly and consistently associated with
smoking heaviness (TAG 2010; Thorgeirsson et al.
2010). This SNP is in high LD with rs16969968 (TAG
2010). For caffeine use, a genetic risk score was created
based on eight SNPs that reached genome-wide signiﬁ-
cance in their association with coffee consumption in a
large meta-analysis (Cornelis et al. 2014). The number
of coffee consuming increasing alleles at each locus
was summed across all eight variants for each individ-
ual. Alleles were weighted according to the magnitude
of the effect size (β) for coffee consumption, taken from
the recent meta-analysis by Cornelis et al. (2014).
Table 1 provides more detailed information on all SNPs,
including the risk alleles, frequencies of these risk alleles
and effect sizes.
Figure 1 Overview of three methods employed to investigate the association between smoking and caffeine consumption. The asterisk (*)
means that the original measure from TAG (2010) was smoking cessation (0 = current smoking, 1 = former smoking); this was deﬁned here
as smoking persistence (0 = former smoking, 1 = current smoking). NTR, Netherlands Twin Register ; ALSPAC, Avon Longitudinal Study of
Parents and Children; TAG, Tobacco, Alcohol and Genetics Consortium; GWAS, genome-wide association studies
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Smoking measures
All NTR and ALSPAC participants were classiﬁed as cur-
rent smokers, former smokers or never smokers. Avariable
on smoking heaviness (cigarettes smoked per day) was
available for current smokers in both cohorts. A more de-
tailed explanation of these variables is available in a publi-
cation on the observational associations between smoking
and caffeine consumption inNTRandALSPAC (Treur et al.
2016). For the current paper, variables were deﬁned that
reﬂect smoking initiation (0=never smokers, 1 = former
and current smokers), current smoking (0=never and
former smokers, 1= current smokers) and smoking persis-
tence (0= former smokers, 1 = current smokers).
Caffeine measures
In both NTR and ALSPAC, questions were asked about
the consumption of caffeinated coffee, tea and cola, while
in the NTR, an additional question on energy drinks was
included. From these questions, daily total caffeine con-
sumption (in mg) and daily caffeine consumption
through coffee (in mg) were calculated for all partici-
pants. More details on the making of these variables are
given elsewhere (Treur et al. 2016). For bivariate twin
modelling (method 1; NTR data only), a dichotomous
variable was created where 1 SD above the mean was
chosen as a cut-off point, distinguishing ‘low’ from ‘high’
coffee users (0 = low [≤1 SD above the mean, N=8599],
1 =high [>1 SD above the mean, N=1769]) and ‘low’
from ‘high’ total caffeine users (N=6863 and
N=1197, respectively) This cut-off point was determined
for men and women separately.
Statistical analyses
Bivariate genetic modelling
The bivariate twin model estimates the inﬂuence of addi-
tive genetic effects (A), common environmental effects
shared by twins from the same family (C) and unique
environmental effects (E) on smoking and caffeine use,
as well as how much of the correlation between
smoking and caffeine use is due to A, C and E. Brieﬂy,
MZ twins are 100% genetically similar, while DZ twins
share ~50% of their segregating genes; both types of
twins may share their environment. In the case of one
trait, a higher resemblance between MZ twins than be-
tween DZ twins indicates an inﬂuence of additive genetic
factors (A). If the correlation between DZ twins is
greater than half the correlation between MZ twins,
the common environment that is shared by both twins
(C) is also of inﬂuence. When the correlation between
MZ twins is lower than 1, this must be due to unique
environmental factors (E). The inﬂuence of genes and
environment on the correlation between smoking and
caffeine (bivariate) is deduced from the correlation be-
tween smoking in twin 1 and caffeine in twin 2. When
this ‘cross-correlation’ is higher in MZ than in DZ twin
pairs, an inﬂuence of A is implied. When the DZ cross-
correlation is greater than half the MZ cross-correlation,
the inﬂuence of C is suggested. When the MZ cross-
correlation is lower than the correlation between
smoking and caffeine in one person, an inﬂuence of E
is implied. For more elaborate descriptions and compara-
ble bivariate twin designs, see, e.g. Kiecolt, Aggen, &
Kendler (2013); Posthuma et al. (2003) and Poelen
et al. (2008).
Table 1 SNPs utilized in Mendelian randomization analysis.
SNP Chr Closest gene RA/NRA Effect size RAF Genotyped/imputed Imputation quality
NTR ALSPAC NTR ALSPAC NTR ALSPAC
Smoking heaviness
rs1051730 15 CHRNA3 A/G 1.03 0.32 0.33 G G — —
Coffee consumption
rs1260326 2 GCKR C/T 0.04 0.63 0.60 G G — —
rs1481012 4 ABCG2 A/G 0.06 0.89 0.90 G G — —
rs6968554 7 AHR G/A 0.13 0.64 0.64 G I — 0.99
rs7800944 7 MLXIPL C/T 0.05 0.27 0.29 I I 0.79 0.97
rs17685 7 POR A/G 0.07 0.26 0.28 G G — —
rs6265 11 BDNF C/T 0.05 0.80 0.81 G G — —
rs2472297 15 CYP1A1 T/C 0.15 0.27 0.27 G G — —
rs9902453 17 EFCAB5 G/A 0.04 0.49 0.45 G I — 0.99
Effect sizes represent β coefﬁcients and were obtained from TAG (2010) and Cornelis et al. (2014). ALSPAC, Avon Longitudinal Study of Parents and
Children; Chr, chromosome; RA, risk allele (smoking or coffee consumption increasing allele); NRA, non-risk allele; NTR, Netherlands Twin Register;
RAF, risk allele frequency in the total study sample of ALSPAC and NTR participants; SNP, single nucleotide polymorphism.
4 Jorien L. Treur et al.
© 2016 The Authors Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction Biology
To estimate genetic and environmental inﬂuences, bi-
variate structural equation modelling was performed in
OpenMx (Boker et al. 2011). There were two models,
one with current smoking (0=never and former
smokers, 1= current smokers) and coffee use (0= low,
1=high) and one with current smoking and total caf-
feine use (0= low, 1=high). In these so-called liability
threshold models, an underlying liability resulting from
genetic and environmental factors is assumed. A thresh-
old divides individuals into current smokers and non-
current smokers and into high and low caffeine users.
The thresholds depend on the prevalence of current
smoking and high caffeine use, respectively (Falconer &
Mackay 1996; Wray & Visscher 2015). Age was included
as a moderator on the thresholds, allowing prevalence to
differ with age (categories: <20, 20–24, 25–34, 35–44,
45–54 and ≥55 years).
The ﬁrst step of genetic modelling was to ﬁt a bivariate
saturated model to data from ﬁve sex-by-zygosity groups
(MZM, DZM, MZF, DZF and DOS twin pairs). Next, the ef-
fects of A, C and E on smoking, coffee/caffeine and the ge-
netic and environmental correlations were estimated in a
bivariate ACE model. Several constraints were imposed
during model ﬁtting, which are described in the Results
section. The ﬁt of submodels was tested with likelihood
ratio tests, following a χ2 distribution where the amount
of d.f. (degrees of freedom) is equal to the difference in
d.f. of the two models. Constraints were retained when
they did not signiﬁcantly deteriorate the ﬁt (P-value
≥0.05).
LD-score regression
Genome-wide association meta-analysis results were
available for cigarettes smoked per day, smoking initiation
(0=never smokers, 1= former and current smokers) and
smoking cessation (0= current smoking, 1 = former
smoking) (TAG 2010) and for cups of coffee per day
(Cornelis et al. 2014). Smoking cessation was deﬁned as
smoking persistence (0= former smokers, 1= current
smokers) by multiplying the genetic correlation by 1.
The meta-analyses on smoking and coffee included
GWA studies of 16 and 28 population-based samples of
European ancestry, including up to 46481 individuals
and 91462 individuals, respectively. Findings are thus
not restricted, or speciﬁc, to one single population.
Genetic correlations were estimated using LD-score
regression (Bulik-Sullivan et al. 2015a). The intuitive
concept behind this technique is that for highly polygenic
traits, SNPs that tag many neighbouring SNPs due to
strong LD have a higher chance of tagging a causal locus.
In contrast, SNPs that are in relatively weak LD with
their neighbours tag fewer causal loci. One can therefore
formulate the expected effect size for a SNP in a GWAS as
a function of the degree of LD, sample size in a GWAS,
number of SNPs considered and the heritability. To esti-
mate genetic correlation, the effect size estimates of all
SNPs included in GWAS of two phenotypes of interest
are utilized. First, the association between a particular
SNP and phenotype 1 (represented by a Z score) is multi-
plied by the association between that same SNP and phe-
notype 2. Second, the product thereof is regressed on the
LD that the SNP has with all neighbouring SNPs (i.e. the
LD score). As such, it is possible to estimate genetic corre-
lation between two traits solely based on observed sum-
mary statistics. We used precomputed LD scores based
on meta-analyses of individuals of European ancestry
that are publicly available (from: https://github.com/
bulik/ldsc). LD-score regression can be utilized even
when there is sample overlap, because effect size inﬂation
due to sample overlap will equally impact all SNPs, re-
gardless of their LD score, and inﬂation due to sample
overlap inﬂates the intercept, not the slope.
Mendelian randomization analysis
By measuring genetic variants strongly predictive of
smoking and caffeine use instead of these behaviours
themselves, MR minimizes effects of confounding and re-
verse causation (Fig. 2). In Stata (version 9.0; StataCorp
Figure 2 Principle of bidirectional Mendelian randomization (MR)
applied to the association between smoking and caffeine use. Smoking
SNP = rs1051730; caffeine use SNP score = genetic risk score of caf-
feine use based on eight SNPs (rs1260326, rs1481012, rs6968554,
rs7800944, rs17685, rs6265, rs2472297 and rs9902453). (a) Under
a causal effect of smoking on caffeine use, the smoking SNP should,
through its effect on smoking heaviness, increase caffeine use (among
smokers only). (b) Under a causal effect of caffeine use on smoking,
the caffeine use SNP score should, through its effect on caffeine
use, increase smoking heaviness, smoking initiation and/or smoking
cessation. MR rules out reverse causation [represented by the arrow
going from caffeine use to the smoking SNP in (a) and from smoking
to the caffeine use SNP score in (b)]. An important aspect of MR is
that the genotype in question should not be associated with con-
founders [represented by the arrow going from the smoking SNP
to confounders in (a) and from the caffeine use SNP score to con-
founders in (b)]
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LP, College Station, TX, USA), regression analyses were
ﬁrst carried out between the smoking SNP and smoking
behaviour and between the caffeine use risk score and caf-
feine consumption to test their instrumental value. The
smoking SNP should be associated with number of ciga-
rettes smoked per day, and the caffeine use risk score
should be associated with amount of caffeine consumed
per day. Next, the smoking SNP was associated with
caffeine use (Fig. 2a) and the caffeine use SNP score
with smoking (Fig. 2b), to test causal effects. Data from
NTR and ALSPAC cohorts were pooled to increase power
and corrected for age (continuous), gender (only relevant
in NTR, 0=male, 1= female) and sample (0=NTR,
1=ALSPAC). For NTR participants, analyses were
corrected for family clustering by utilizing the robust
cluster option in Stata. We also tested whether genetic risk
variants for smoking and caffeine were associated with
potential confounding factors (educational attainment
and social class).
RESULTS
Bivariate genetic modelling
In the whole twin sample, 11.6% was aged <20 years,
30.1% 20–24 years, 22.3% 25–34 years, 18.2% 35–
44 years, 7.0% 45–54 years and 10.8% ≥55 years. The
association of age with smoking and caffeine prevalence
was estimated separately in men and women by a regres-
sion of age (β) on the thresholds in the liability model.
Prevalences were equal across twin birth order but not
across zygosity group. On this saturated model with 46
free parameters (Table 2-A; model 1), we applied several
constraints. Dropping age from the model resulted in a
signiﬁcant deterioration of the model ﬁt (model 2), so it
was kept in. The modelled prevalence of current smoking
and high coffee/total caffeine use across age groups are
depicted in Table S1. The effect of age on smoking and
coffee was different for men than for women (models 3
and 4), so it was not constrained across gender. Within
person correlations between smoking and coffee (cross-
trait-within twin) and cross-correlations between
smoking in twin 1 and coffee in twin 2 (cross-trait cross-
twin correlations) could be constrained across twin birth
order (models 5 and 6). No differences in twin resem-
blance were found between men and women (model 7).
For current smoking and total caffeine use, the same con-
straints were allowed (Table 2-B; models 1 till 7). Twin
correlations from the best-ﬁtting saturated models are
given in Table 3.
Next, an ACE model was ﬁtted for current smoking
and coffee use (Table 2-A; models 8 till 15). Dropping C
for coffee, for smoking, or for the overlap between coffee
and smoking was permitted (models 9–11). Dropping A
for coffee, for smoking, or for the overlap, and E for the
overlap resulted in a signiﬁcant deterioration of the ﬁt
(models 12 till 15), and these effects were thus retained.
For current smoking and total caffeine use, similar
submodels were applied (Table 2-B; models 8 till 15),
resulting in a best-ﬁtting model without any inﬂuence
of C and without E for the overlap.
Table 4 depicts parameter estimates for the full
ACE and best-ﬁtting AE models. Variation in current
smoking was mostly due to additive genetic factors
(ACurrentSmoking = 76% [70–79%] in a bivariate model
with coffee and ACurrentSmoking = 74% [66–80%] with to-
tal caffeine) with the remainder being due to unique en-
vironmental factors (ECurrentSmoking = 24% [19–30%] and
ECurrentSmoking = 26% [20–34%], respectively). About half
of the variation in coffee use was due to additive genetic
factors (ACoffee = 53% [48–58%]) and the other half to
unique environmental factors (ECoffee = 47% [40–54%]).
For total caffeine, results were similar (ATotalCaffeine = 49%
[47–58%] and ETotalCaffeine = 51% [42–60%]). See Figs S1
and S2 for a graphical representation of these models,
with all parameter estimates.
A genetic correlation of r0.47 (0.38 to 0.56) was
found between smoking and coffee and of r0.44 (0.35
to 0.53) between smoking and total caffeine. There was
a unique environmental correlation of r0.30 (0.15 to
0.45) between smoking and coffee. The unique environ-
mental correlation between smoking and total caffeine
was r0.00 (0.00 to 0.00), meaning that all correlation
between the two traits was attributed to other sources
(namely genetic). Phenotypic overlap between current
smoking and coffee was mostly due to additive genetic
factors (ACurrentSmoking-Coffee = 75% [62–87%]), with some
inﬂuence of unique environmental factors (ECurrentSmoking-
Coffee = 25% [13–38%]). Between current smoking and
total caffeine, the overlap was completely due to genetic
factors.
LD-score regression
The genetic correlation between cigarettes per day and
cups of coffee per day, as calculated by LD-score regression,
was r0.44 (0.14 to 0.74). This conﬁrms the results from
the bivariate twin models of the same genetic risk factors
inﬂuencing current smoking and high coffee/total caffeine
consumption. Between smoking initiation and cups of
coffee per day, the genetic correlation was lower at
r0.28 (0.11 to 0.45), and between smoking persistence
and cups of coffee per day, it was r0.25 (0.04 to 0.46).
Mendelian randomization analysis
As expected, the caffeine use SNP score was strongly
associated with a higher coffee and total caffeine
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consumption in mg of caffeine per day (Fig. S3-A; β coef-
ﬁcient 66.5 [45.0–87.90] and 86.7 [64.4–109.1],
respectively). The smoking SNP (rs1051730) was asso-
ciated with more cigarettes smoked per day (Fig. S3-B;
0.6 [0.2–1.1]), conﬁrming previous studies.
The caffeine use SNP score was not associated with
educational attainment or social class, while for the
smoking SNP, there was some minor evidence for a nega-
tive association in ALSPAC only (Table S3). This associa-
tion is most likely spurious, as discussed elsewhere
(Taylor et al. under review). Brieﬂy, Taylor et al. found
no consistent evidence for a causal, negative effect of
smoking on socio-economic status when analysing the ef-
fect of the smoking SNP on different measures of socio-
economic status in ALSPAC and the Nord-Trøndelag
Health Study.
There was no association between the smoking SNP
and caffeine consumption (total or coffee only) in cur-
rent, former or never smokers (Fig. S4-A), thus providing
no support for a causal effect of smoking on caffeine.
Also, none of the pooled analyses showed an association
between the caffeine use SNP score and smoking beha-
viour, meaning that there is no evidence for a causal ef-
fect of caffeine use on smoking behaviour (Fig. S4-B).
See Tables S4 and S5 for MR analyses at all timepoints
in ALSPAC.
DISCUSSION
The association between smoking and caffeine consump-
tion was investigated with three methods: bivariate twin
modelling, LD-score regression and MR. All three sets of
analyses pointed to a similar conclusion of shared genetic
factors explaining the phenotypic overlap between
smoking and caffeine use. The lack of evidence for causal
effects between smoking and caffeine use could have been
due to low power.
It is the ﬁrst time that the association between
smoking and caffeine use was investigated in Dutch twins.
Our results are in line with earlier US-based twin studies
that found genetic correlation between smoking and caf-
feine use (Swan et al. 1996, 1997; Hettema et al. 1999;
Kendler et al. 2008). Apart from one (Swan et al. 1996),
these studies also found unique environmental correla-
tion between smoking and caffeine use (Swan et al.
1997; Hettema et al. 1999; Kendler et al. 2008) as we
did for smoking and coffee use. For smoking and total
caffeine use, we did not ﬁnd unique environmental cor-
relation. In the present study, we analysed caffeine as
high versus low users and smoking as current versus
non-current smokers. To demonstrate that our conclu-
sions were not affected by the dichotomization of caffeine
(which may result in a loss of statistical power), we also
applied a bivariate ACE model with caffeine as a
continuous measure (mg per day). The results of these
analyses were very similar with the exception that there
was, in addition to a genetic correlation, also a unique
environmental correlation for both smoking and coffee
and smoking and total caffeine (Tables S3–S5). The ﬁt
of this alternative model was poor when compared with
the fully saturated model, probably because the continu-
ous measure of caffeine was severely (right) skewed. In
spite of the variation in measures of smoking and caf-
feine use, the present study corroborates previous twin
studies. The genetic correlations of r0.47 (for coffee only)
and r0.44 (for total caffeine) are very similar to those
found between cigarettes per day and cups of coffee per
day (r0.43; Swan et al. 1996) and between heavy
smoking and heavy coffee use (r0.43; Swan et al.
1997). An important strength of our study is that it in-
volves a large sample of >10 000 twins, making it twice
as large as the biggest previous twin study (Swan et al.
1997). Even though the Netherlands is seen as a typical
‘coffee drinking’ country (Fredholm 2011; Ferdman
2014), the genetic underpinnings of the overlap between
smoking and caffeine were similar compared with US
populations.
Genetic correlations as estimated by twin modelling
were remarkably similar to the genetic correlation be-
tween cigarettes per day and cups of coffee per day based
on effect size estimates of two large GWA meta-analyses.
Some caution is warranted with the comparison of these
two methods, however, given the difference in measures
of smoking and caffeine use. A major advantage of LD-
score regression is that genetic correlation is based on
data of multiple (European) populations, instead of just
one (Dutch) population in the case of twin modelling.
There was also evidence for an overlap between SNPs as-
sociated with cups of coffee per day and smoking initia-
tion and smoking persistence. Genetic variants that
increase coffee consumption thus also increase the
chance of becoming a smoker and decrease the chance
of quitting smoking once started. The latter is in agree-
ment with observational studies ﬁnding an inverse rela-
tion between quitting smoking and coffee consumption
(Sorlie & Kannel 1990; Olsen 1993; Fernandez et al.
1997). The present study is the ﬁrst to correlate SNPs as-
sociated with smoking behaviour with SNPs associated
with coffee consumption.
In Dutch and British individuals, there was no evi-
dence for causal effects of smoking on caffeine use, or
vice versa, as also suggested from the bivariate twin data,
in which the unique environmental correlation was low
or zero (De Moor et al. 2008). MR analyses may have
been underpowered to pick up on causal effects. Given
the study’s sample size, an increase of 29mg of caffeine
with each cigarette per day would have provided evi-
dence for a causal effect of smoking on caffeine (power
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of 0.80), as opposed to the increase of 5mg that we
found. Whereas each extra mg of caffeine was associated
with +0.01 cigarettes per day, an increase of 0.04 would
have pointed to a causal association of caffeine on
smoking (Brion, Shakhbazov, & Visscher 2013).
Although the eight SNPs included in the caffeine use
SNP score were taken from a study looking exclusively
at coffee use (Cornelis et al. 2014), the two most
signiﬁcant SNPs (rs6968554 and rs2472297) were re-
cently also positively associated with total caffeine (cof-
fee + tea+ cola), coffee and tea, but not with cola alone
(McMahon et al. 2014). A potential limitation of MR is
pleiotropy. Under pleiotropy, one genetic variant or set
of variants is associated with multiple phenotypes. It
could, e.g. be the case that the caffeine use SNP score di-
rectly affects smoking (not acting through a causal effect
of caffeine use on smoking), which would undermine the
principle of MR. Pleiotropic effects can be minimized by
selecting genetic instruments with effects that plausibly
act directly on the trait in question. Also, when different
(sets of) SNPs separately have the same association with
the outcome of interest, it is less likely that this is due to
pleiotropy (Davey Smith & Hemani 2014). In the present
study, MR analyses were therefore repeated with a ge-
netic risk score for caffeine including only rs6968554
and rs2472297. Both of these SNPs play a clear role in
the metabolism of caffeine, and it is unlikely that they
have a direct effect (e.g. not acting through caffeine
use) on smoking. The results of these analyses were very
similar to the risk score based on eight SNPs (data not
shown), suggesting that pleiotropy did not affect the
results.
This study was the ﬁrst to combine multiple methods
with the aim of unravelling the nature of the co-
morbidity between smoking and caffeine use. Our ﬁn-
dings point to shared genetic factors underlying the asso-
ciation between smoking and caffeine use, not ruling out
that there is an additional (smaller) inﬂuence of causal
effects. At least, some of the genetic risk factors for
smoking overlap with genetic risk factors for caffeine
use. This ﬁnding suggests that initiating smoking may
be especially undesirable for heavy caffeine users, given
their genetic susceptibility to smoke more heavily or to
more easily become nicotine dependent. Because
smoking is likely to be initiated before heavy caffeine
use is manifested, a more important implication may be
that smokers who are also heavy caffeine users might,
on average, ﬁnd it more difﬁcult to quit because of their
genetic background. To conﬁrm our ﬁndings and to fur-
ther clarify the complex association between these (ad-
dictive) behaviours, further research is required.
Especially, causal effects from smoking on caffeine or vice
versa need to be explored through MR analysis in larger
samples.
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Table S3. Structural equation models to explore additive
genetic (A), common environmental (C) and unique
environmental (E) inﬂuences on current smoking and
caffeine use in mg per day, and on their overlap
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(N=8,060) from the best-ﬁtting saturated models
Table S5. Estimates of additive genetic (A), common en-
vironmental (C) and unique environmental (E) inﬂuences
on current smoking and coffee use in mg per day
(N=10,368) and on current smoking and total caffeine
use in mg per day (N=8,060), from the full and the
best-ﬁtting bivariate genetic models
Table S6. Associations between the caffeine use SNP
score and the smoking SNP and confounding variables
in the Netherlands Twin Register (NTR) and the Avon Lon-
gitudinal Study of Parents and Children (ALSPAC)
Table S7. Mendelian Randomization analyses between
the caffeine use SNP score and daily caffeine consump-
tion (in mg) and smoking behaviour in the Avon Longitu-
dinal Study of Parents and Children (ALSPAC)
Table S8. Mendelian Randomization analyses between
the smoking SNP and smoking behaviour and daily
caffeine consumption (in mg) in the Avon Longitudinal
Study of Parents and Children (ALSPAC)
Figure S1. Path estimates for bivariate genetic models
on current smoking & coffee and on current smoking &
total caffeine. A = additive genetic factors, C = common
genetic factors, E = unique environmental factors. Both
the initial models and the best-ﬁtting models are shown.
Figure S2. Path estimates for bivariate genetic models
on current smoking & coffee and on current smoking &
total caffeine. A = additive genetic factors, C = common
genetic factors, E = unique environmental factors. Here,
genetic (between A1 and A2), common environmental
(between C1 and C2) and unique environmental (E1
and E2) correlations are shown. Calculation of the ge-
netic correlation was based on the following formula:
aCurrentSmoking * aCurrentSmoking-Coffee / √(a2CurrentSmoking) *
√(a2CurrentSmoking-Coffee + a2Coffee), where aCurrentSmoking and
aCoffee represent the path loadings going from A1 to
‘Current smoking’ and from A2 to ‘Coffee’, respectively
and aCurrentSmoking-Coffee represents the path loading going
from A2 to ‘Current smoking’ in Figure S1. Environmen-
tal correlations were calculated in the same way. Both
the initial models and the best-ﬁtting models are shown.
Figure S3. Instrumental value of the genetic risk scores.
The forest plots show associations between the caffeine
use SNP score and total caffeine use and caffeine from
coffee in mg per day (A) and between the smoking SNP
and cigarettes smoked per day (B). NTR = Netherlands
Twin Register; ALSPAC = Avon Longitudinal Study of
Parents and Children.
Figure S4. MR analyses testing causal effects. The forest
plots show associations between the smoking SNP and to-
tal caffeine use and caffeine from coffee in mg per day (A)
and between the caffeine use SNP score and smoking be-
haviour (cigarettes smoked per day, smoking persistence,
smoking initiation and current smoking) (B). NTR =
Netherlands Twin Register; ALSPAC = Avon Longitudinal
Study of Parents and Children.
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